T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
+$2.5B |
| 2 |
Kenvue
KVUE
|
+$1.3B |
| 3 |
Halliburton
HAL
|
+$1.16B |
| 4 |
Charles Schwab
SCHW
|
+$836M |
| 5 |
Boeing
BA
|
+$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.52B |
| 2 |
Apple
AAPL
|
+$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.47B |
| 5 |
Intuit
INTU
|
+$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Berry Corp
BRY
$251M
| $142K | ﹤0.01% |
17,272
+2,284
| +15% | +$18.8K |
|
2577
Veritone
VERI
$201M
| $140K | ﹤0.01% |
54,132
+11,514
| +27% | +$29.8K |
|
2578
Phathom Pharmaceuticals
PHAT
$874M
| $139K | ﹤0.01% |
13,394
-38
| -0.3% | -$394 |
|
2579
SIGA Technologies
SIGA
$624M
| $139K | ﹤0.01% |
26,342
+947
| +4% | +$5K |
|
|
GRTS
2580
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $139K | ﹤0.01% |
80,535
+15,800
| +24% | +$27.3K |
|
|
DSKE
2581
DELISTED
Daseke, Inc. Common Stock
DSKE
| $139K | ﹤0.01% |
26,949
+848
| +3% | +$4.37K |
|
2582
Treace Medical Concepts
TMCI
$442M
| $138K | ﹤0.01% |
10,480
+1,323
| +14% | +$17.4K |
|
2583
Rimini Street
RMNI
$414M
| $137K | ﹤0.01% |
62,070
+18,635
| +43% | +$41.1K |
|
2584
KRONOS Worldwide
KRO
$721M
| $136K | ﹤0.01% |
17,488
+613
| +4% | +$4.77K |
|
2585
TAL Education Group
TAL
$6.37B
| $136K | ﹤0.01% |
14,900
| – | – |
|
2586
Driven Brands
DRVN
$3B
| $134K | ﹤0.01% |
10,606
+1,100
| +12% | +$13.9K |
|
2587
1-800-Flowers.com
FLWS
$326M
| $134K | ﹤0.01% |
19,042
+511
| +3% | +$3.6K |
|
2588
LifeVantage
LFVN
$143M
| $134K | ﹤0.01% |
20,700
-5,200
| -20% | -$33.7K |
|
2589
Smith & Wesson
SWBI
$416M
| $134K | ﹤0.01% |
+10,307
| New | +$134K |
|
2590
ARKO Corp
ARKO
$563M
| $132K | ﹤0.01% |
18,341
+1,176
| +7% | +$8.46K |
|
2591
GrowGeneration
GRWG
$89.1M
| $132K | ﹤0.01% |
45,162
+3,226
| +8% | +$9.43K |
|
2592
Senseonics Holdings
SENS
$357M
| $132K | ﹤0.01% |
217,900
| – | – |
|
2593
Alto Ingredients
ALTO
$89M
| $131K | ﹤0.01% |
29,600
-8,100
| -21% | -$35.8K |
|
2594
Cullinan Oncology
CGEM
$382M
| $131K | ﹤0.01% |
14,402
| – | – |
|
2595
Enanta Pharmaceuticals
ENTA
$178M
| $131K | ﹤0.01% |
+11,678
| New | +$131K |
|
2596
The ONE Group
STKS
$82.3M
| $130K | ﹤0.01% |
23,554
| – | – |
|
|
VTNR
2597
DELISTED
Vertex Energy, Inc
VTNR
| $130K | ﹤0.01% |
29,046
+6,597
| +29% | +$29.5K |
|
2598
Integral Ad Science
IAS
$1.41B
| $129K | ﹤0.01% |
+10,787
| New | +$129K |
|
2599
Inogen
INGN
$225M
| $129K | ﹤0.01% |
24,548
+8,643
| +54% | +$45.4K |
|
|
ROVR
2600
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $129K | ﹤0.01% |
20,596
-136,243
| -87% | -$853K |
|